Synaptic vesicle glycoprotein 2A (SV2A) is a prototype synaptic vesicle protein regulating
action potential-dependent neurotransmitters release. SV2A also serves as a specific�…

Synaptic vesicle glycoprotein 2A (SV2A) is specifically expressed in the membranes of
synaptic vesicles and modulates action potential-dependent neurotransmitter release. To�…

Dysfunction of synaptic neurotransmitter release is closely involved in the pathogenesis of
various central nervous system diseases. Synaptic vesicle glycoprotein 2A (SV2A) is a�…

Levetiracetam's (Keppra�) binding site and its subsequent identification as the synaptic
vesicle protein 2A (SV2A) has opened a new and successful avenue for drug discovery�…

Synaptic vesicle protein 2A (SV2A) has become an attractive target of investigation because
of its role in the pathophysiology of epilepsy; SV2A is expressed ubiquitously throughout the�…

The epilepsy-linked gene SV2A, has a number of potential roles in the synaptic vesicle (SV)
life cycle. However, how loss of SV2A function translates into presynaptic dysfunction and�…

Synaptic vesicle proteins 2 (SV2) were discovered in the early 80s, but the clear
demonstration that SV2A is the target of efficacious anti-epileptic drugs from the racetam�…

Synaptic vesicle protein 2A (SV2A) involvement has been reported in the animal models of
epilepsy. The aim of this study was to investigate the expression of SV2A in human�…

Abstract Background SV2A, SV2B and SV2C are synaptic vesicle proteins that are
structurally related to members of the major facilitator superfamily (MFS). The function and�…

Abstract Synaptic vesicle glycoprotein-2 (SV2) is a family of proteins consisting of SV2A,
SV2B, and SV2C. This protein family has attracted attention in recent years after SV2A was�…